All three are investigational, long-acting amylin-based candidates being studied for weight management
I n December 2024, Torrent Pharma acquired three diabetes brands from Boehringer Ingelheim, including those with Empagliflozin, to strengthen its anti-diabetes portfolio In November 2024, AstraZeneca presented promising early data for its obesity pipeline, including AZD5004, an oral GLP-1 receptor blocker, at Obesity Week 2024
So pharmacists can help patients interpret pre-op instructions or paperwork from the prescriber if they have them
These include neurodegenerative conditions like Parkinsons and Alzheimers, as glutathione protects brain cells from oxidative damage
Candussi CJ, Bell W, Thompson AS, Knppel S, Gaggl M, Svtnika M et al (2025) Risk of hypothyroidism in meat-eaters, fish-eaters, and vegetarians: a population-based prospective study